Journal
ARCHIVES OF MEDICAL RESEARCH
Volume 54, Issue 2, Pages 79-85Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.arcmed.2022.12.007
Keywords
SAV1; Tumor Suppressor; Hypoxia; Breast Cancer; Prognosis
Categories
Ask authors/readers for more resources
In breast cancer, hypoxia is associated with poor prognosis. The tumor suppressor SAV1 is downregulated in cancer cells, but its expression profile and importance in BC are limited. This study aimed to investigate SAV1 expression under normoxia and hypoxia, and its potential in BC prognosis. The results showed that SAV1 expression is lower in BC samples and tumor cell lines compared to normal samples. Lower levels of SAV1 were associated with worse survival curves and may be a risk factor for BC.
Background. In breast cancer (BC), hypoxia is associated with poor prognosis. Protein Salvador homolog 1 (SAV1) acts as a tumor suppressor and is downregulated in the cancer cells. However, there is limited data on the expression profile of SAV1 and its importance in BC. It has not been studied to evaluate this phenomenon in a hypoxic microenvironment yet. Aim. This study aimed to investigate SAV1 expression profiles under normoxia and hypoxia, and the potential of SAV1 in BC prognosis. Methods. Gene and protein expression analyses were performed using Real-Time quantitative PCR (RT-qPCR) and immunocytochemistry (ICC), respectively, and in silico analyses were performed using The Cancer Genome Atlas (TCGA). The survival curves were constructed using KMplotter. Results. SAV1 expression was lower in BC samples and tumor cell lines than in normal samples. The SAV1 mRNA levels were reduced in hypoxic estrogen receptor positive (ER (+)) tumors, which were associated with a lower survival probability as compared to normoxic ER (+) tumors. Furthermore, lower levels of SAV1 were found in advanced cancer stage samples, which are associated with worse survival curves and can be a risk factor for BC. Conclusions. These data suggest a potential prognostic role of SAV1 in BC, with lower expressions associated with worse prognosis. (c) 2023 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available